placeholder image
B. Zinman All authors
About
Publications While At 开云体育
selected publications
Journal Article
  • Efficacy and safety of empagliflozin in older patients in the EMPA-REG OUTCOME(R) trial. 
    Age and Ageing. 2019
  • 2017;40:777-83. 
    Diabetes care. 2017
  • Association of glycemic variability in type 1 diabetes with progression of microvascular outcomes in the Diabetes Control and Complications Trial. 
    Diabetes care. 2017
  • Liraglutide and renal outcomes in type 2 diabetes. 
    New England Journal of Medicine. 2017
  • Liraglutide and cardiovascular outcomes in type 2 diabetes. 
    New England Journal of Medicine. 2016
  • LEADER 2: baseline calcitonin in 9340 people with type 2 diabetes enrolled in the Liraglutide Effect and Action in Diabetes: Evaluation of cardiovascular outcome Results (LEADER) trial: preliminary observations. 
    Diabetes, Obesity & Metabolism. 2015
  • LEADER 3--lipase and amylase activity in subjects with type 2 diabetes: baseline data from over 9000 subjects in the LEADER Trial. 
    Pancreas. 2014
  • Design of the liraglutide effect and action in diabetes: evaluation of cardiovascular outcome results (LEADER) trial. 
    American Heart Journal. 2013
  • Long-term effect of rosiglitazone and/or ramipril on the incidence of diabetes. 
    Diabetologia. 2011
  • Long-term renal outcomes of patients with type 1 diabetes mellitus and microalbuminuria: an analysis of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications cohort. 
    Archives of Internal Medicine. 2011
    • Contact
    full name
  • B. Zinman
    • Quick Info
    Publications
    Publications in the past 10 years based solely on publications while at 开云体育. Publications in prior years appear in grey.
    Collaboration